Insertion duplication mutagenesis and allelic replacement mutagenesis are among the most commonly utilized approaches for targeted mutagenesis in bacteria. However, both techniques are limited by a variety of factors that can complicate mutant phenotypic studies. To circumvent these limitations, multiple markerless mutagenesis techniques have been developed that utilize either temperature-sensitive plasmids or counterselectable suicide vectors containing both positive-and negative-selection markers. For many species, these techniques are not especially useful due to difficulties of cloning with Escherichia coli and/or a lack of functional negative-selection markers. In this study, we describe the development of a novel approach for the creation of markerless mutations. This system employs a cloning-independent methodology and should be easily adaptable to a wide array of Gram-positive and Gram-negative bacterial species. The entire process of creating both the counterselection cassette and mutation constructs can be completed using overlapping PCR protocols, which allows extremely quick assembly and eliminates the requirement for either temperature-sensitive replicons or suicide vectors. As a proof of principle, we used Streptococcus mutans reference strain UA159 to create markerless in-frame deletions of 3 separate bacteriocin genes as well as triple mutants containing all 3 deletions. Using a panel of 5 separate wild-type S. mutans strains, we further demonstrated that the procedure is nearly 100% efficient at generating clones with the desired markerless mutation, which is a considerable improvement in yield compared to existing approaches.
Streptococcus mutans is a Gram-positive bacterial species that resides within multispecies oral biofilms formed on human tooth surfaces. It is also considered to be one of the principal species associated with dental caries initiation (6, 7, 34, 35, 44, 47, 52) . S. mutans genetic research has benefited tremendously from the many genetic tools that have been adapted for use in studies of the organism (4, 5, 13, 15, 22, 25, 26, 29, 33, 45, 51) . For genetic studies of S. mutans, defined mutations are usually engineered in either of two ways: insertion duplication mutagenesis via single-crossover homologous recombination or marked allelic replacement mutagenesis using double-crossover homologous recombination (25, 27, 41) . Both approaches are highly reliable strategies for mutagenesis and are simple to engineer, but they also have the potential to create unwanted artifacts that could influence the outcome of a genetic study. For example, insertion duplication mutations often result in the production of truncated proteins. Rarely is it known with certainty whether the protein fragments actually influence mutant phenotypes. Furthermore, due to significant polar effects downstream of the mutation site, both insertion duplication mutagenesis and allelic replacement mutagenesis are of limited utility within operons. In some cases, these issues have been addressed by creating allelic replacement mutants by the use of antibiotic resistance cassettes that lack their endogenous terminators (1, 32, 53) . In theory, such constructs permit efficient read-through from upstream promoters and are often referred to as nonpolar. However, since the antibiotic cassettes also contain their own promoters, downstream gene expression patterns are subject to read-through from both the upstream promoter and the antibiotic cassette promoter. This, too, creates a dubious situation for phenotypic analyses, as downstream genes are likely to be differentially regulated.
The preferred approach to circumvent these limitations is through the creation of markerless mutations. Typically, a markerless mutation is engineered using a two-step integration and excision strategy that utilizes either a conditionally replicating temperature-sensitive vector (3, 17, 43) or a suicide vector containing both positive-and negative-selection markers for counterselection (49) . When available, counterselectable suicide vectors are often preferred to temperature-sensitive replicons, since the negative-selection marker eliminates clones that have not completed the excision step. This can significantly reduce the effort required to identify the markerless mutant clones. Depending on the construct design, counterselectable mutation constructs can yield a maximum of 50% of the recombinants with a mutant genotype, whereas the remaining clones contain a wild-type genotype (33) . Consequently, it is still necessary to screen the resulting isolates to identify the mutant strains.
Currently, only a few negative-selection markers are available for use in bacteria, which greatly limits the utility of the technique for most species. For organisms that are unable to properly metabolize sucrose polymers or galactose, both the levansucrase (sacB) (49) and galactokinase (galK) (46) genes function well as selective markers. However, numerous species such as S. mutans already carry these genes. Alternatively, a recipient strain can be constructed in which an organism is rendered sensitive to a substrate through mutagenesis. Frequently, the upp mutation is used to create sensitivity to 5-fluorouracil (10, 12, 20, 24) . Using S. mutans, we were able to create a galactose-sensitive recipient strain by mutagenizing the galKTE operon (33) . This approach resulted in a strong negative selection in S. mutans that was used for the facile creation of a variety of unmarked mutations, such as in-frame deletions, truncations, reporter gene insertions, fusion proteins, and point mutations. The obvious drawback is the requirement for a mutant recipient strain. During our studies, we identified several instances in which the recipient background impacted the phenotypes of our markerless mutant strains (unpublished results). More recently, a Cre-loxP system has been adapted for use in S. mutans (5) . The Cre-loxP approach has the advantage of circumventing the requirement for a mutant recipient strain and has been used to create unmarked gene deletions in a large variety of bacteria (5, 8, 21, 28, 30, 36, 39, 42) . However, the resulting mutant strains also retain the loxP site after the excision step (5, 30, 36) , which could be problematic for the creation of various types of mutations, such as truncations, point mutations, fusion proteins, etc.
Recently, a host strain-independent negative-selection marker developed in Escherichia coli (18) was adapted for use as a counterselectable marker in Enterococcus faecalis (23) . This system utilizes a point mutant form of the pheS gene encoding the highly conserved phenylalanyl-tRNA synthetase alpha subunit. In a previous E. coli study, it was shown that a PheS protein containing an A294G substitution has the ability to aminoacylate phenylalanine analogs such as p-chloro-phenylalanine (p-Cl-Phe) (19) . Thus, by incorporating this point mutant form of pheS into a vector, it was possible to perform negative selection in the presence of p-Cl-Phe (18, 23) . Presumably, the toxicity is derived from the incorporation of p-Cl-Phe into cellular proteins. The immediate advantage of this system is its utility in a wild-type organism. In addition, it has been suggested that, since PheS is highly conserved in bacteria, this approach should be adaptable for use in other species (23) . Thus, we began by examining the efficacy of p-Cl-Phe negative selection in S. mutans. Subsequently, we devised a novel cloning-independent counterselection methodology for the creation of markerless mutation constructs. This system completely abrogated the requirement for suicide vectors or temperaturesensitive replicons and greatly simplified the process of construct assembly. Using the cloning-independent approach, we easily created unmarked single, double, and triple in-frame deletion mutants. In addition, we tested the system using multiple wild-type backgrounds and demonstrated that the yield of isolates with the desired mutation was consistently nearly 100%.
MATERIALS AND METHODS
Primers, bacterial strains, and culture conditions. The primers used in this study are shown in Table 1 . All S. mutans strains were grown in brain heart infusion broth (BHI; Difco) or on BHI agar plates ( Table 2) . S. mutans strains were grown anaerobically (in an atmosphere consisting of 85% N 2 , 10% CO 2 , and 5% H 2 ) at 37°C. DNA constructs were introduced into S. mutans by the use of natural transformation according to published protocols (38 ). General DNA manipulation. Phusion DNA polymerase, Taq DNA polymerase, restriction enzymes, T4 DNA ligase, and other DNA-modifying enzymes were all purchased from New England BioLabs. Phusion DNA polymerase was used for overlapping PCR. Taq DNA polymerase was used for screening clones.
Construction of the IFDC1 counterselection cassette. In order to obtain the site-directed mutant of pheS* (GCC314GGC), the wild-type open reading frame of pheS was first amplified with PCR using primer pair phesF and phesR. The PCR product was cloned into pGEM-T easy vector (Promega) to generate pWTphes. pWTphes was then used as a template for inverse PCR using the phosphorylated primer pair phesmF and phesmR. The PCR product was digested with DpnI followed by ligation of the PCR fragments and transformation of E. coli. Plasmids containing the expected mutant pheS (GCC314GGC) were confirmed by sequencing and designated pMTphes ( Table 2 ).
The IFDC1 cassette (a pheS*-ermAM two-gene operon driven by the ldh promoter) was constructed by an overlapping PCR ligation strategy. First, the promoter region of the constitutive lactate dehydrogenase gene ldh was generated by PCR with primer pair ldhF-bamHI and ldhR. The pheS* open reading frame was generated by PCR using pMTphes as a template and the primer pair pheSF-ldh and phesR. The ermAM open reading frame was generated by PCR using primer pair ermF-phes and ermR-HindIII. There are overlapping regions between the three amplicons, which allowed a subsequent overlapping PCR using primer pair ldhF-BamHI and ermR-HindIII. The resulting 2.2-kb amplicons were digested with BamHI and HindIII and ligated into the corresponding sites of pDL278 to obtain pIFDC1.
Construction of the IFDC2 counterselection cassette. In order to prevent mutagenesis of the wild-type, chromosomal copy of pheS through recombination, we introduced a series of silent mutations into the region of pheS* after codon 314. The new in-frame-deletion cassette was named IFDC2. In order to generate IFDC2, three oligonucleotides (mphesF1, mphesF2, and mphesR) were synthesized. Each has 60 nucleotides; together, they spanned the entire 140-bp region of pheS that was targeted for mutagenesis. There is also a 20-bp overlapping region between mphesF2 and the other two primers, which allowed them to be ligated into a single 140-bp fragment by the use of overlapping PCR with primer pair mphesF1 and mphesR. The resulting 140-bp amplicon was cloned into the pGEM-T Easy vector to generate pMTmphes and was confirmed by sequencing. The IFDC2 cassette was also created using an overlapping PCR ligation strategy. Briefly, by the use of pIFDC1 as a template, a 1.1-kb region containing the ldh promoter and partial pheS was PCR amplified with primer pair ldhF-BamHI and phesR-mol. The same template was used to amplify ermAM with primer pair ermF-mol and ermR-hindIII. Using pMTmphes as a template, the 140-bp mutagenized region of pheS* was PCR amplified with primer pair mphesF1 and mphesR. The three amplicons were mixed and used as a template for a subsequent PCR using primer pair ldhF-BamHI and ermR-HindIII. The resulting 2.2-kb amplicon was digested with BamHI and HindIII and ligated into the corresponding sites of pDL278 to create pIFDC2.
Generation of single-mutation in-frame deletion strains. nlmA (SMU.150) markerless in-frame deletion strain ZX-4IFD was constructed by a two-step transformation procedure. For the first step, a 1-kb region upstream of nlmA was PCR amplified with primer pair 150upF and 150upR-ldh, while a 1.2-kb region downstream of nlmA was PCR amplified with primer pair 150dnF-erm and 150dnR. The IFDC1 or IFDC2 cassette was PCR amplified with primer pair ldhF and ermR. The three amplicons contain overlapping regions, which allowed a subsequent overlapping PCR using primer pair 150upF and 150dnR. The resulting 4.4-kb amplicon was transformed into UA159, and transformants were selected on BHI plates containing erythromycin. The resulting strain was named ZX-4IFDC1 or ZX-4IFDC2. For the second transformation, 1-kb upstream and 1.2-kb downstream fragments surrounding nlmA were generated by PCR using primer pair 150upF and 150upR-IFD and primer pair 150dnF-IFD and 150dnR. Each amplicon had regions that overlap with regions of the other amplicon; those amplicons yielded a 2.2-kb amplicon when mixed and amplified using primers 150upF and 150dnR. The resulting amplicon was transformed into ZX-4IFDC1 or ZX-4IFDC2 and selected on BHI plates containing p-Cl-Phe. nlmD (SMU.423) markerless in-frame deletion strain ZX-6IFD was constructed using the same strategy. For the first transformation, 1-kb upstream and downstream fragments flanking nlmD were generated by PCR using primer pair 423upF and 423upR-ldh and primer pair 423dnF-erm and 423dnR. Both amplicons have regions overlapping with the IFDC2 cassette, which was amplified with primer pair ldhF and ermR. For the second transformation, the 1-kb upstream and downstream fragments were generated by PCR using primer pair 423upF and 423upR-IFD and primer pair 423dnF-IFD and 423dnR. Overlapping PCR was used to ligate the fragments using primer pair 423upF and 423dnR.
nlmC (SMU.1914c) markerless in-frame deletion strain ZX-5IFD was created as described above. For the first transformation, the 1-kb upstream and downstream fragments were generated by PCR using primer pair 1914upF and 1914upR-ldh and primer pair 1914dnF-erm and 1914dnR. Both amplicons have regions overlapping with the IFDC2 cassette. For the second transformation, the 1-kb upstream and downstream fragments were generated by PCR using primer pair 1914upF and 1914upR-IFD and primer pair 1914dnF-IFD and 1914dnR. Overlapping PCR was used to ligate the fragments using primer pair 1914upF and 1914dnR.
Generation of double in-frame deletion strains. nlmA-nlmD double in-frame deletion strain ZX-46IFD was constructed using the same protocol as described for ZX6IFD, except that ZX-4IFD was used as the starting strain. nlmC-nlmD double in-frame deletion strain ZX-56IFD was constructed using the same protocol as described for ZX-6IFD, except that ZX-5IFD was used as the starting strain. nlmA-nlmC double in-frame deletion strain ZX-45IFD was constructed using the same protocol as described for ZX-5IFD, except that ZX-4IFD was used as the starting strain.
Generation of triple in-frame deletion strain. nlmA-nlmC-nlmD triple inframe deletion strain ZX-456IFD was constructed using the same protocol as described for ZX-6IFD, except that ZX-45IFD was used as the starting strain.
Verification of in-frame deletion strains. Genomic DNA was extracted from all of the putative in-frame deletion strains and used as a template for PCR verification. Wild-type genomic DNA was used as a control. To identify nlmA in-frame deletions, genomic DNA was PCR amplified using primer pair 150pF and 150dnR. The expected in-frame deletion yields a 1.4-kb amplicon, while the wild type yields a 1.6-kb amplicon. The nlmD in-frame deletions were confirmed using primer pair 423pF and 423dnR. The expected in-frame deletion yields a 1-kb amplicon, while the wild type yields a 1.3-kb amplicon. The nlmC in-frame deletions were confirmed using primer pair 1914pF and 1914dnR. The expected in-frame deletion yields a 1.1-kb amplicon, while the wild type yields a 1.3-kb amplicon. We randomly selected 2 triple-mutant isolates and sequenced each of the mutation sites using primer pair 150upF and dnR (nlmA), primer pair 423upF and dnR (nlmD), and primer pair 1914upF and dnR (nlmC).
Generation of nlmA (SMU.150) in-frame deletions in multiple S. mutans strains. In order to assess the efficiency of cloning-independent IFDC2 mutagenesis in S. mutans, UA159 and 4 additional S. mutans wild-type strains (UA140, 25175, L13, and CL1) were selected to create in-frame deletions of nlmA. Each of these strains was previously determined to possess nlmA loci nearly identical to those of UA159 (unpublished data). Therefore, it was possible to employ the same mutagenesis procedure as described for ZX-4IFD. For each strain, 33 colonies were randomly chosen after counterselection on p-Cl-Phe plates. Each colony was patched onto BHI plates containing erythromycin. Erythromycinsensitive strains were scored as mutant clones, whereas antibiotic-resistant clones were scored as background. These results were also further verified by PCR using the primer pair 150pF and 150dnR. Three independent experiments were performed with all 5 strains, and the results were averaged. 
RESULTS
Creation of a hybrid positive-and negative-selection cassette. It was previously demonstrated that a point mutant pheS* gene encoding an A294G substitution in E. coli PheS or an A312G substitution in E. faecalis PheS results in a pronounced sensitivity to the phenylalanine analog p-chloro-phenylalanine (p-Cl-Phe) (18, 23) . Given the high sequence conservation of PheS among bacteria, we reasoned that the same mutation in the S. mutans PheS would likely result in a similar sensitivity to p-Cl-Phe. In order to identify the appropriate residue for mutagenesis, we used ClustalW to perform a multiple sequence alignment of the PheS proteins from a variety of distantly related Gram-positive and Gram-negative species. As shown in Fig. 1A , A312 in Enterococcus faecalis (23) , A294 in E. coli (19) , A317 in Myxococcus xanthus, A303 in Bacteroides fragilis, A322 in Streptomyces coelicolor, and A314 in S. mutans are all strictly conserved. Therefore, as described in Materials and Methods, we used inverse PCR to engineer a point mutation in codon 314 of S. mutans pheS to change it from GCC to GGC (Fig. 1B) . This resulted in a mutant PheS protein containing an A314G substitution. In order to test whether this mutant pheS* would also function as a negative-selection marker, we incorporated this gene into a hybrid IFDC1 cassette, which contained both positive-and negative-selective markers combined into one artificial operon (Fig. 1B) . Transcription of the entire cassette was driven solely by the highly expressed S. mutans lactate dehydrogenase (ldh) promoter.
The pheS* open reading frame was engineered as a translation fusion to the ldh promoter followed by a promoterless erythromycin resistance ermAM cassette that still retained its original ribosome binding site. With this configuration, the acquisition of erythromycin resistance would be indicative of pheS* transcription. Next, the IFDC1 cassette was cloned onto E. coli-S. mutans shuttle vector pDL278 and tested for its functionality for positive and negative selection in S. mutans. As shown in Fig. 2 , this cassette provided stringent selection in the presence of either erythromycin or p-Cl-Phe.
Cloning-independent assembly of markerless mutation constructs. Given the success of the initial test of IFDC1, we Primer binding sites are denoted by small arrows, whereas primers containing overlapping sequences are denoted by bent arrows. As described in Materials and Methods, the S. mutans pheS open reading frame was cloned into pGEM-T Easy vector and mutagenized using inverse PCR to introduce a GCC-to-GGC point mutation into codon 314. The pheS* cassette was then amplified with PCR and mixed with PCR amplicons of the ldh promoter and promoterless ermAM cassette. Both the pheS* amplicon and the ermAM amplicon were engineered to contain overlapping sequences that facilitated their assembly by PCR into a single cassette (IFDC1) controlled by the constitutive ldh promoter. decided to use this cassette for a novel markerless mutagenesis strategy. In the classic approach, 2 homologous DNA fragments flanking the intended mutation site are ligated together onto a suicide vector containing both positive-and negativeselection markers (17, 33, 49) . In our case, those markers would be supplied by the IFDC1 cassette. However, we reasoned that it should be possible to forgo the cloning steps altogether by adopting an allelic replacement strategy (Fig. 3) . In order to test this approach, we targeted the gene encoding the bacteriocin mutacin IV (SMU.150 [nlmA]) for an in-frame deletion. After the first transformation, we were able to easily isolate erythromycin-resistant clones that had replaced the nlmA open reading frame with IFDC1 (Fig. 4A) . However, we were surprised to discover that the second transformation yielded no clones on the p-Cl-Phe plates ( Fig. 4B and C) . Subsequent analyses determined that the wild-type copy of pheS had recombined with the mutant pheS* of IFDC1 (data not shown). Therefore, it was necessary to reconstruct IFDC1 by the use of a pheS* cassette with lower homology to the wild-type locus.
Creation of the next-generation cassette IFDC2. Initially, we replaced the S. mutans pheS* in IFDC1 with several other pheS* open reading frames we had created using the genomic DNA from closely related species. We found that this approach offered no selection in the presence of p-Cl-Phe (data not shown). Consequently, it was necessary to continue using the S. mutans pheS* cassette, albeit we deemed it necessary to further alter the sequence of pheS* to reduce its homology to the wild-type gene. By engineering a series of silent mutations in the remaining codons after the pheS314AG mutation site, we created a new pheS* cassette (mpheS) that still retained the amino acid sequence of the original cassette but exhibited much lower homology at the nucleotide level downstream of pheS314AG ( Fig. 5A and B) . The new mpheS cassette was then used in place of pheS* for the second-generation IFDC2 counterselection cassette. Using this cassette, we repeated the selection procedure described for Fig. 3 and once again targeted nlmA for in-frame deletion. With IFDC2, the second transformation step yielded dramatically different results in the presence of p-Cl-Phe selection. We observed p-Cl-Phe-resistant colonies at a frequency that was highly suggestive of a successful transformation (Fig. 5C and D) . To further confirm the utility of this system, we repeated the nlmA mutagenesis and (50) and nlmC (SMU.1914c; also referred to as cipB), for in-frame deletion (14, 37) . For all 3 mutations, we obtained similar results. After the second transformation and negative selection on p-Cl-Phe, all of the randomly screened colonies exhibited the expected deletion (Fig. 6A to C) . Lastly, we chose several confirmed nlmA in-frame deletion clones and used the same approach to create unmarked triple deletion strains of nlmA, nlmD, and nlmC (Fig. 6D) . As a final confirmation, we selected 2 of the resulting triple mutants and sequenced each of the mutation sites to verify the expected deletions (data not shown). IFDC2 is highly efficient for counterselection in multiple S. mutans wild-type backgrounds. Given our success with mutagenesis of S. mutans reference strain UA159, we were next curious to determine whether our mutagenesis system would be broadly applicable for use with other S. mutans strains as well. Consequently, we used the same approach to engineer markerless nlmA deletions in 4 additional strains that we had previously determined to carry nlmA. The performance of the system was evaluated by assaying the proportion of colonies that had excised the IFDC2 cassette after the counterselection step. For all 5 strains, we consistently detected from 93 to 100% of the clones with the expected genotypes and few, if any, background clones ( Table 3) . As expected, counterselection also resulted in the markerless deletion of nlmA in all 5 strains (Fig. 6E) . Thus, the results with respect to the performance of the system were quite similar for all of the strains, with nearly every tested clone exhibiting the desired mutation.
DISCUSSION
In the current report, we describe a highly efficient cloningindependent counterselection approach for creating markerless mutations. This system is based upon the proven utility of the pheS* gene as a negative-selection marker in the presence of p-Cl-Phe (23) . For this approach, we incorporated the pheS* open reading frame into a hybrid positive-and negative-selection cassette, which facilitated the allelic replacement strategy we used to introduce the constructs. In addition, by eliminating FIG. 5 . Creation of the IFDC2 second-generation cassette. (A) As described in Materials and Methods, a series of silent mutations were engineered in the region downstream of codon 314 to create the new mpheS negative-selection cassette. Three overlapping oligonucleotides containing the desired pheS silent mutations were synthesized. The oligonucleotides were mixed and subjected to overlapping PCR to produce an amplicon carrying the 3Ј portion of pheS. The remaining portion of pheS and the ermAM cassette were both amplified from IFDC1. All 3 amplicons were mixed in a single reaction and subjected to overlapping PCR to generate the final IFDC2 product. Primer binding sites are indicated by small arrows, whereas bent arrows indicate primers containing overlapping sequences. (B) The nucleotide sequence of the 3Ј region of mpheS was aligned to wild-type pheS by the use of ClustalW. Codon 314 is enclosed within a box. Next, nlmA was targeted for in-frame deletion with the IFDC2 cassette. After transforming UA159 with the IFDC2 mutagenesis construct and selection on erythromycin, confirmed mutants were subjected to a second transformation to remove the IFDC2 cassette and selected using p-Cl-Phe. The results from the negative-control reaction receiving no DNA are shown in panel C, while results from the transformation reaction are shown in panel D. This experiment was performed 3 times with similar results. the cloning requirement for construction, we were able to reliably assemble all of the mutation constructs via overlapping PCR within 1 to 2 days, which is a considerable reduction in time and effort compared to cloning-based approaches. Another benefit of the cloning-independent approach is that it circumvents the issues of toxicity associated with introducing heterologous DNA fragments into E. coli. For example, E. coli routinely transcribes from any S. mutans promoters located within the cloned fragments of mutagenesis constructs. As a result, we have encountered instances where, due to the foreign gene products produced, particular constructs were unstable in E. coli (unpublished results). Likewise, cloned heterologous DNA from extremely AT-rich organisms is also known to be exceptionally unstable in E. coli, due to frequent deletions and rearrangements (11) . Thus, a cloning-independent methodology should be particularly useful for constructing markerless mutations in these species. Furthermore, we consistently obtained nearly 100% of the p-Cl-Phe-resistant transformants with the expected excision of IFDC2 (Table 3) . To the best of our knowledge, our approach represents the first markerless mutagenesis system capable of generating such a high proportion of unmarked mutants in a wild-type background. In contrast to plasmid-based approaches, it was largely unnecessary to screen for the mutant clones after the final selection step, since the vast majority contained the desired mutation. Furthermore, if a further confirmation of a mutant genotype is desired, one need only to patch clones onto antibiotic plates and verify their sensitivity. PCR screening is unnecessary. As noted by Kristich et al., the high conservation of PheS in bacteria also suggests that the pheS* gene should be adaptable for use in a wide range of species (23) . Indeed, we found that the particular alanine residue required for creating PheS* is strictly conserved in a diverse array of both Grampositive and Gram-negative organisms (Fig. 1A) . Thus, our system is likely to be widely applicable for the creation of unmarked mutations in bacteria.
While we now have the markerless mutagenesis system fully optimized, the system went through several iterations before reaching its current state, due to the need for improvements upon the pheS* negative-selection cassette. In our case, we found that p-Cl-Phe selection was unacceptably inefficient at suppressing background growth unless the pheS* cassette was very highly expressed. Presumably, this is because the A314G mutant PheS* must compete with the endogenous wild-type PheS to form complexes with PheT (31). Initially, we had fused pheS* to the synthetic lactococcal CP25 promoter (16) . Previously, we found CP25 to be a suitable promoter for ensuring strong, constitutive gene expression in S. mutans. However, for negative selection with pheS*, it did not function nearly as well as the S. mutans lactate dehydrogenase (ldh) promoter (data not shown). In our experience, the S. mutans ldh promoter gives even higher gene expression than CP25 (unpublished results). Given that we expressed pheS* as a translation fusion to the ldh promoter, it is also certainly possible that differences in translation efficiency could have further contributed to the greater success of the experiments performed with ldh versus CP25. Another hurdle we encountered was due to an apparent high rate of recombination between the pheS* cassette and the chromosomal copy of pheS. Initially, we thought that this could be prevented simply by substituting a pheS* cassette created from another closely related organism. However, we tested several other pheS* cassettes and found that strategy to be unsuccessful. The problem was finally solved by introducing a series of silent mutations downstream of the pheS* point mutation site to reduce the overall homology of the cassette with the wild-type pheS (Fig. 5A and B) . We were also mindful of the engineered silent mutations to avoid inadvertently impeding the translation of the cassette due to the introduction of multiple rare codons. Currently, it is unknown whether pheS silent mutations are required for the successful utilization of p-Cl-Phe counterselection in organisms other than S. mutans. Such an approach was apparently unnecessary for use in E. faecalis (23) . However, if this system is to be adapted for use in other species, it is advisable to start by synthesizing or constructing a synthetic pheS* with reduced homology to the wildtype gene. In that way, any potential issues with pheS recombination can be avoided altogether.
